MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cmi.2020.07.041

Медицинская библиотека · Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2020

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.

Garcia-Vidal Carolina, Sanjuan Gemma, Moreno-García Estela, Puerta-Alcalde Pedro, Garcia-Pouton Nicole, Chumbita Mariana, Fernandez-Pittol Mariana, Pitart Cristina, Inciarte Alexy, Bodro Marta, Morata Laura, Ambrosioni Juan, Grafia Ignacio, Meira Fernanda, Macaya Irene, Cardozo Celia, Casals Climent, Tellez Adrian, Castro Pedro, Marco Francesc, García Felipe, Mensa Josep, Martínez José Antonio, Soriano Alex, COVID-19 Researchers Group

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

To describe the burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID-19).

METHODS

We performed an observational cohort study of all consecutive patients admitted for ≥48 hours to the Hospital Clinic of Barcelona for COVID-19 (28 February to 22 April 2020) who were discharged or dead. We describe demographic, epidemiologic, laboratory and microbiologic results, as well as outcome data retrieved from electronic health records.

RESULTS

Of a total of 989 consecutive patients with COVID-19, 72 (7.2%) had 88 other microbiologically confirmed infections: 74 were bacterial, seven fungal and seven viral. Community-acquired co-infection at COVID-19 diagnosis was uncommon (31/989, 3.1%) and mainly caused by Streptococcus pneumoniae and Staphylococcus aureus. A total of 51 hospital-acquired bacterial superinfections, mostly caused by Pseudomonas aeruginosa and Escherichia coli, were diagnosed in 43 patients (4.7%), with a mean (SD) time from hospital admission to superinfection diagnosis of 10.6 (6.6) days. Overall mortality was 9.8% (97/989). Patients with community-acquired co-infections and hospital-acquired superinfections had worse outcomes.

CONCLUSIONS

Co-infection at COVID-19 diagnosis is uncommon. Few patients developed superinfections during hospitalization. These findings are different compared to those of other viral pandemics. As it relates to hospitalized patients with COVID-19, such findings could prove essential in defining the role of empiric antimicrobial therapy or stewardship strategies.

Для цитирования: Garcia-Vidal Carolina, Sanjuan Gemma, Moreno-García Estela, Puerta-Alcalde Pedro, Garcia-Pouton Nicole, Chumbita Mariana, Fernandez-Pittol Mariana, Pitart Cristina, Inciarte Alexy, Bodro Marta, Morata Laura, Ambrosioni Juan, Grafia Ignacio, Meira Fernanda, Macaya Irene, Cardozo Celia, Casals Climent, Tellez Adrian, Castro Pedro, Marco Francesc, García Felipe, Mensa Josep, Martínez José Antonio, Soriano Alex, COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020. DOI: 10.1016/j.cmi.2020.07.041.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.